National (US) as well as Global recognition of cannabis derived medicinal extract and inhalant benefits has not only become widespread, but is universally accepted as scientific fact. Now predominantly legal in many state venues, cannabis production, its derivatives and distribution through legitimate channels, is under consideration by most to become legal if it isn’t already. More so, these derivatives… when produced and cultivated under exacting conditions… have become high-demand. That is, when high quality, controlled production is utilized, high yields and top pharma-grade results are netted. That equates to greater profits all around to the producer as his/her product of higher quality will demand a higher price. And as the demand by both populace and the medical community seeking non-addictive, non-biologically destructive alternatives to synthetic drugs grows, the market will require greater amounts of and better quality product.
The challenge facing all producers is the lack of adequate production facility availability, high infrastructure costs and the need for bona-fide, precise engineered provision of those environments as repeatable, reliable and consistent means for production.